会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • Drugs for relieving carbonyl stress and peritoneal dialysates
    • 用于缓解羰基应激和腹膜透析的药物
    • EP2070535A1
    • 2009-06-17
    • EP09002868.9
    • 1999-08-23
    • Kurokawa, KiyoshiMiyata, ToshioTOKAI UNIVERSITY EDUCATIONAL SYSTEM
    • Toshio, Miyata
    • A61K31/4415A61P7/08
    • A61K31/203A61K31/155A61K31/4965A61K33/00A61M1/287Y10S514/832Y10S514/866A61K2300/00
    • Drugs for relieving carbonyl stress in the peritoneal cavity to be used in peritoneal dialysates which contain carbonyl compound-trapping agents as the active ingredient. Carbonyl compounds formed and accumulated during peritoneal dialysis are inactivated or eliminated by carbonyl compound-trapping agents such as aminoguanidine. Carbonyl compounds formed during the sterilization and storage of peritoneal dialysates are eliminated by preliminarily bringing into contact with the trapping agents. Further, addition of the trapping agents to peritoneal dialysates or circulation of the trapping agents by using a cartridge for trapping carbonyl compounds makes it possible to eliminate carbonyl compounds originating in the blood of the patients which flow into the peritoneal cavity as the dialysis proceeds. Thus, modification of proteins in the peritoneal cavity can be inhibited and peritoneal damage in association with peritoneal dialysis can be relieved.
    • 用于缓解腹膜腔内羰基应激的药物用于含有羰基化合物捕获剂作为活性成分的腹膜透析液。 在腹膜透析过程中形成并积累的羰基化合物被羰基化合物捕获剂如氨基胍灭活或消除。 通过预先与捕获剂接触来消除在腹膜透析液的灭菌和储存过程中形成的羰基化合物。 此外,通过使用用于捕获羰基化合物的盒向腹膜透析液中添加捕获剂或使捕获剂循环,可以随着透析的进行而消除源自流入腹膜腔的患者的血液中的羰基化合物。 因此,可以抑制腹膜腔内蛋白质的改变,并且可以缓解与腹膜透析相关的腹膜损伤。